Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Duration of Study: A short-term acute study will likely employ a different KLOW dosage guide than a long-term chronic investigation
Afamelanotide (Scenesse) is the FDA-approved pharmaceutical formulation with proven safety and efficacy from Phase 3 clinical trials, delivered as a controlled-release subcutaneous implant
Prep the site Prep the site Wipe your chosen site with an alcohol swab and let it dry
Adding both aerobic and resistance exercise further helps burn calories and mitigate muscle loss
Results vary from person to person, and ongoing support from your doctor helps you stay on track and adjust the plan as needed
US$ 26.23
US$ 29.76
US$ 20.68
US$ 26.17
US$ 20.80
US$ 26.09
US$ 21.46
